Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Sales | 2,076 | 3,111 | 9,631 | 3,928 | 7,293 |
| Gross Profit | 2,076 | 3,111 | 9,631 | 3,928 | 7,293 |
| Operating Expenses | 5,349 | 5,737 | 9,711 | 6,626 | 9,664 |
| Operating Income | -3,273 | -2,626 | -80 | -2,698 | -2,371 |
| Interest Expense | 285 | 2 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | -510 | 4,069 |
| Pre-tax Income | -3,558 | -2,628 | -80 | -3,208 | 1,698 |
| Net Income Continuous | -3,558 | -2,628 | -80 | -3,208 | 1,698 |
| Net Income | $-3,558 | $-2,628 | $-80 | $-3,208 | $1,698 |
| EPS Basic Total Ops | -0.04 | -0.02 | 0.00 | -0.03 | 0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | 0.00 | -0.03 | 0.03 |
| EPS Diluted Total Ops | -0.04 | -0.02 | 0.00 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | 0.00 | -0.03 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.02 | 0.00 | -0.03 | -0.04 |
| EBITDA(a) | $-2,988 | $-2,626 | $-80 | $-2,692 | $-2,364 |